Chronic Pain Management Pioneer, FlexifyMe, Secures INR 10 Crore in Seed Funding Round Led by IvyCap Ventures and Flipkart Ventures

FlexifyMe, a trailblazing Chronic Pain Management Platform, has successfully concluded its Seed funding round, garnering INR 10 Crore from prominent investors IvyCap Ventures and Flipkart Ventures


Notable participation in the funding round also came from respected investors GSF, Chandigarh Angels Network, Venture Catalyst, and Ah Ventures.


The company has unveiled strategic plans for utilizing these funds to revolutionize chronic pain management by incorporating cutting-edge technology and progressive exercises. 


The primary objective is to deliver enduring relief and elevate workplace wellness to unprecedented levels.


Citing a statement, the global prevalence of chronic pain, impacting over 2 billion individuals, is exacerbated by sedentary lifestyles and postural misalignments.


As India’s foremost chronic pain management solution, FlexifyMe intends to deploy the funds to fortify its technology and introduce progressive exercises.


The company’s overarching goal is to assist corporations in understanding ergonomic challenges, eliminating postural misalignments, boosting employee productivity, and ensuring continuous health monitoring. 


The company anticipates contributing to stress alleviation and enhancing lifestyle disorders.


Founded in October 2021 by seasoned entrepreneurs Manjeet Singh and Amit Bhayani, FlexifyMe is dedicated to reshaping conventional physiotherapy through its groundbreaking AI motion-tracking technology.


Vikram Gupta, Founder and Managing Partner, commented on the investment, stating, “FlexifyMe’s innovative approach convinced us of its potential to revolutionize healthcare. 


We believe in the power of FlexifyMe’s unique platform, backed by its dedicated team, to transform the lives of millions suffering from chronic pain. 


The ambitious goals set by the founders align seamlessly with our vision for impactful investments.”


Co-founders Manjeet Singh and Amit Bhayani expressed gratitude for the investment round and the trust bestowed by their investors in their vision. 


They emphasized their commitment to leveraging advanced technology in healthcare to aid one million individuals in finding relief from chronic pain by 2027.